KSM Research Collaboration Aimed at Early Cancer Detection

NEWS & RESOURCES

Maccabi’s KSM Research and Innovation Center & PrognomiQ Announce Research Collaboration Aimed at Early Cancer Detection

Maccabi's KSM Research and Innovation Center & PrognomiQ Announce Research Collaboration Aimed at Early Cancer Detection Press Release

KSM, the Research and Innovation Center of Maccabi Health Services, Israel’s leading HMO, and PrognomiQ – a California-based healthcare company focused on harnessing the power of multi-omics data to transform the detection and early treatment selection and monitoring of cancer and other complex diseases – today announced the launch of an innovative research collaboration.

Read the full article here.

Share this page:

Related Articles

deep multi-omics study press release

January 8, 2024

PrognomiQ’s Latest Research Demonstrates the Potential of its Multi-omics Liquid Biopsy Platform in Early-Stage Detection of Lung Cancer

Read More
PrognomiQ Appoints Raj Garg to its Board of Directors Press Release

August 9, 2023

PrognomiQ Appoints Raj Garg to its Board of Directors

Read More
PrognomiQ's Multi-omics Liquid Biopsy Platform Demonstrates Promising Results in Early-Stage Cancer Detection of Non-Small Cell Lung Cancer Press Release

January 23, 2023

PrognomiQ’s Multi-omics Liquid Biopsy Platform Demonstrates Promising Results in Early-Stage Cancer Detection of Non-Small Cell Lung Cancer

Read More